Patents by Inventor Johan Holst

Johan Holst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH MODULATES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES
    Publication number: 20120014991
    Abstract: Adjuvant for mucosal vaccines which modulates the effects of substances, including vaccine antigens in contact with mucosal body surfaces.
    Type: Application
    Filed: September 23, 2011
    Publication date: January 19, 2012
    Applicant: BIOTEC PHARMACON ASA
    Inventors: Jan RAA, Aud Katherine Herland BERSTAD, Hilde Sunove Waleur BAKKE, Bjorn HANEBERG, Inger LISE HAUGEN, Johan HOLST, Liba JANAKOVA, Gro Ellen KORSVOLD, Fredrik OFTUNG
  • Combination B/C vaccines
    Patent number: 8007815
    Abstract: Combination vaccines for treating or preventing Neisseria meningitidis infection are described. The vaccines include Neisseria meningitidis serogroup B proteoliposomic vesicles and Neissera meningitidis serogroup C conjugated oligosaccharides.
    Type: Grant
    Filed: May 28, 1999
    Date of Patent: August 30, 2011
    Assignees: Novartis AG, Statens Institutt for Folkehelse
    Inventors: Dan M. Granoff, Howard Raff, Ingeborg S. Aaberge, Bjorn Haneberg, Johan Holst
  • 85kDa neisserial antigen
    Patent number: 7700119
    Abstract: An 85 kDa antigen from Neisseria meningitidis and Neisseria gonorrhoeae has been cloned, sequenced and expressed. The antigen is common to diverse strains, serogroups and serotypes of N. meningitidis, and also to N. gonorrhoeae, N. polysaccharia and N. lactamica. The protein sequences of N. meningitidis (serogroups A and B) and N. gonorrhoeae are highly homologous.
    Type: Grant
    Filed: November 1, 2005
    Date of Patent: April 20, 2010
    Assignee: Novartis Vaccines and Diagnostics SRL
    Inventors: Marzia Monica Giuliani, Mariagrazia Pizza, Rino Rappuoli, Johan Holst
  • 85kDa neisserial antigen
    Publication number: 20060233827
    Abstract: An 85kDa antigen from Neisseria meningitidis and Neisseria gonorrhoeae has been cloned, sequenced and expressed. The antigen is common to diverse strains, serogroups and serotypes of N. meningitidis, and also to N. gonorrhoeae, N. polysaccharia and N. lactamica. The protein sequences of N. meningitidis (serogroups A and B) and N. gonorrhoeae are highly homologous.
    Type: Application
    Filed: November 1, 2005
    Publication date: October 19, 2006
    Applicants: Novartis Vaccines and Diagnostics, S.r.l., Statens Institutt for Folkehelse
    Inventors: Marzia Giuliani, Mariagrazia Pizza, Rino Rappuoli, Johan Holst
  • Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
    Publication number: 20030104010
    Abstract: Adjuvant for mucosal vaccines which modulates the effects of substances, including vaccine antigens in contact with mucosal body surfaces.
    Type: Application
    Filed: October 7, 2002
    Publication date: June 5, 2003
    Inventors: Jan Raa, Aud Katherine Herland Berstad, Hilde Sunove Waleur Bakke, Bjorn Haneberg, Inger Lise Haugen, Johan Holst, Liba Janakova, Gro Ellen Korsvold, Fredrik Oftung
  • NOVEL, NON-ANTIGENIC, MUCOSAL ADJUVANT FORMULATION WHICH ENHANCES THE EFFECTS OF SUBSTANCES, INCLUDING VACCINE ANTIGENS, IN CONTACT WITH MUCOSAL BODY SURFACES
    Publication number: 20020009463
    Abstract: Adjuvant for mucosal vaccines which modulates the effects of substances, including vaccine antigens in contact with mucosal body surfaces.
    Type: Application
    Filed: February 23, 2000
    Publication date: January 24, 2002
    Inventors: Jan Raa, Aud Kathrine Herland Berstad, Hilde Bakke, Bjorn Haneberg, Inger Lise Haugen, Johan Holst, Liba Janakova, Gro Ellen Korsvold, Fredrik Oftung